'Granulomatosis with polyangiitis after Pfizer vaccination': a case report.

Therapeutic advances in rare disease Pub Date : 2022-11-04 eCollection Date: 2022-01-01 DOI:10.1177/26330040221130084
Francis Essien, Jordan Evans, Andrew Kyle, Anatoly Urisman, Nicholas Adams
{"title":"'Granulomatosis with polyangiitis after Pfizer vaccination': a case report.","authors":"Francis Essien,&nbsp;Jordan Evans,&nbsp;Andrew Kyle,&nbsp;Anatoly Urisman,&nbsp;Nicholas Adams","doi":"10.1177/26330040221130084","DOIUrl":null,"url":null,"abstract":"<p><p>The advent of COVID-19, caused by the SARS-CoV-2 virus, has resulted in over 541 million cases with 6.32 million deaths worldwide as of June 2022. The devastating consequences of this global pandemic resulted in the expedited generation of mRNA-based vaccines such as the Pfizer-BioNTech and Moderna vaccines. Although the vaccines have been effective, with recent data indicating greater than 95% effectiveness, rare complications have been reported, including manifestations of autoimmune phenomena. Herein, we report a rare case of Granulomatosis with polyangiitis (GPA) in an active duty military male soon after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine.</p>","PeriodicalId":75218,"journal":{"name":"Therapeutic advances in rare disease","volume":"3 ","pages":"26330040221130084"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/2b/10.1177_26330040221130084.PMC10032451.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic advances in rare disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26330040221130084","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

The advent of COVID-19, caused by the SARS-CoV-2 virus, has resulted in over 541 million cases with 6.32 million deaths worldwide as of June 2022. The devastating consequences of this global pandemic resulted in the expedited generation of mRNA-based vaccines such as the Pfizer-BioNTech and Moderna vaccines. Although the vaccines have been effective, with recent data indicating greater than 95% effectiveness, rare complications have been reported, including manifestations of autoimmune phenomena. Herein, we report a rare case of Granulomatosis with polyangiitis (GPA) in an active duty military male soon after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
“接种辉瑞疫苗后并发多血管炎的肉芽肿”:一例报告。
截至2022年6月,由SARS-CoV-2病毒引起的新冠肺炎的出现已导致全球超过5.41亿例病例,632万人死亡。这场全球大流行的毁灭性后果导致了基于信使核糖核酸的疫苗的快速产生,如辉瑞-BioNTech和莫德纳疫苗。尽管疫苗是有效的,最近的数据表明有效性超过95%,但仍有罕见并发症的报道,包括自身免疫现象的表现。在此,我们报告了一例罕见的现役军人男性在接种第一剂Pfizer-BioNTech新冠肺炎疫苗后不久患颗粒增多症伴多血管炎(GPA)的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
0
期刊最新文献
Individualized therapy development for rare diseases: individualized at every step of the way. Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study. Systemic inflammation in Fabry disease: a longitudinal immuno-genetic analysis based on variant stratification. Addressing rare diseases and access to surgical care in Brazil: a call to action. Updated demographics categories to capture the true diversity of an international registry of rare disease patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1